Elder Pharmaceuticals will launch 12 new products this fiscal in the areas of gynaecology, pain management and nutraceuticals. All the products are in the mandate and prescription market and we are targeting gynaecology, pain management and nutraceuticals segments. The company is also planning to spend up to Rs 55 crore in the next two years for increasing its manpower, mainly the sales force, updating its research and development facilities and for brand building exercises.
The company had recently announced the plans to increase its sales and marketing force by 1,000 in the next two years. The firm is also looking to enhance presence in the functional foods market, leveraging on UK-based NutraHealth Care, a company specialising in neutraceutical products, which it had acquired last year.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: